menu
    • menu

    Company profile for Akebia Therapeutics

    NEW Drugs in Dev: 6
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We were founded in 2007 to discover and develop therapeutic solutions leveraging the potential of hypoxia inducible factor—or HIF—biology. We believe HIF-Prolyl Hydroxylase (HIF-PH) inhibition could represent an approach to treating certain conditions where there is unmet need. Our objective is to develop and commercialize these products, starting with our lead compound, vadadustat, an investigational product being studied...
    We were founded in 2007 to discover and develop therapeutic solutions leveraging the potential of hypoxia inducible factor—or HIF—biology. We believe HIF-Prolyl Hydroxylase (HIF-PH) inhibition could represent an approach to treating certain conditions where there is unmet need. Our objective is to develop and commercialize these products, starting with our lead compound, vadadustat, an investigational product being studied in patients with anemia due to chronic kidney disease (CKD).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Akebia TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 First Street, Suite 1400 Cambridge, MA 02142
    Telephone
    Telephone
    +1 617-871-2098
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://akebia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akebia-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/akebiatx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akebia Pharma Discloses Inducement Grants Per Nasdaq LR
    Akebia Pharma Discloses Inducement Grants Per Nasdaq LR

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304710/37519/en/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Akebia Therapeutics to Present at Jefferies Conference
    Akebia Therapeutics to Present at Jefferies Conference

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3302756/37519/en/akebia-therapeutics-to-present-at-the-2026-jefferies-global-healthcare-conference.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Akebia Vadadustat Data Show Reduced Mortality, Published in JASN
    Akebia Vadadustat Data Show Reduced Mortality, Published in JASN

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286638/37519/en/akebia-therapeutics-announces-vadadustat-post-hoc-win-statistics-analysis-demonstrating-statistically-significant-reduction-in-mortality-and-hospitalization-composite-endpoint-publ.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Akebia Therapeutics Issues Inducement Grants Under Nasdaq
    Akebia Therapeutics Issues Inducement Grants Under Nasdaq

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3287150/37519/en/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Akebia Pharma To Share Q1 2026 Financials And Business Updates
    Akebia Pharma To Share Q1 2026 Financials And Business Updates

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3285448/37519/en/akebia-therapeutics-to-report-first-quarter-2026-financial-results-and-discuss-recent-business-highlights.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Akebia Announces 1st Participants Dosed in Ph 1 Trial of AKB-9090
    Akebia Announces 1st Participants Dosed in Ph 1 Trial of AKB-9090

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272448/37519/en/Akebia-Therapeutics-Announces-First-Participants-Dosed-in-Phase-1-Clinical-Trial-of-AKB-9090.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search